California and Germany stand out as well established centers for the life science and healthcare industry. Some of the key areas that are strongly represented are:
- Healthcare IT
- Healthcare and Diagnostics
- Medical Devices
It is essential for global enterprises to tap into the network of complementary companies represented in both of these geographical areas. Cooperation and mutual learning are vital factors in bringing products to market.
The GABA Life Sciences / Healthcare Interest Group is dedicated to enabling and fostering such alliance networks between German and US life science and healthcare industries in order to add value to all participating partners.
Our web site is designed to suit these purposes. Our member database provides a concise profile of every interested company. GABA members can access this database with a personal login and password and find companies that fit their needs. This type of database allows for networking and cross-Atlantic exchange.
Seminars, workshops, and conferences are supporting the exchange of business information and enabling synergy by providing a forum for personal contact. On request, our members can provide market analysis and customized consultancy.
Outlook 2020: Medical Device Opportunities in US vs. Europe
Milppitas, Oct 25, 2016
Microbiome – New Avenues for combating Diseases?
San Francisco, April 12, 2016
Potential Cures for Parkinson’s, Alzheimer’s, and Huntington’s Disease
San Francisco, April 6, 2015
Clinical Evaluation & Investigation of Medical Devices in Europe
Palo Alto, Oct 25, 2013
Shaping a successful Biotech Cluster
San Francisco, Sep 10, 2013
New Challenges for Medical Device Manufacturers and Hospitals
/Risk Management for IT Networks Incorporating Medical Devices
San Francisco, Oct 2, 2012
Wearable Devices: Hype or Help?
Palo Alto, Jun 12, 2012
The Clinical and Commercial Landscape for Oncology Drugs
South San Francisco, May 23, 2012
Social Media and Mobile Health: Creating Value
South San Francisco, Mar 06, 2012
Life Sciences Newsletters
- Decision Making Criteria In Early Drug Development
- Lean Construction in the Life Sciences: Pro and Cons
- Facility Management in the Life Sciences: Optimize Outsourcing